A phase I/II trial of interleukin-15–stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors
2015 · Cytotherapy · 77 citations
https://doi.org/10.1016/j.jcyt.2015.07.011
L
Lucía Fernández
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
1.2K
Citations
19
h-index
28
i10-index
Lucía Fernández is an academic researcher from Spanish National Cancer Research Centre. The author has contributed to research in topics: Immune Cell Function and Interaction & CAR-T cell therapy research & Hematopoietic Stem Cell Transplantation. The author has an h-index of 19, co-authored 40 publications.
ORCID: 0000-0002-6755-6017Papers by this author
worksOptimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy
2021 · Cancers · 30 citations
https://doi.org/10.3390/cancers13030577
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
2021 · Clinical Lymphoma Myeloma & Leukemia · 18 citations
https://doi.org/10.1016/j.clml.2021.01.013
Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
2020 · BMJ Open · 14 citations
https://doi.org/10.1136/bmjopen-2019-029642
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
2021 · Cancer Immunology Immunotherapy · 11 citations
https://doi.org/10.1007/s00262-021-02901-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat